Abstract Submission

Abstract submission is closed.

You must be registered to submit an abstract. The deadline for submission of poster abstracts to be considered for Oral Presentation (Oral or Poster) is 25 June 2018 (extended deadline). This is also the deadline for the Early Registration. After 25 June, abstracts can be submitted for poster presentation only until 20 August 2018.

Abstracts submission requires a title of maximal 150 characters and an abstract text of maximal 300 words. Abstracts will be shown in the conference program in a similar style, however, some editing is possible using HTML code (italic, bold, underline, super- or subscript). Pictures and graphics cannot be included in the abstract. Abstracts have to be assigned to a scientific session: 

Scientific sessions
• Pluripotency and reprograming
• Somatic stem cells and development
• Hematopoietic stem cells
• Stem cells in diseases: cancer stem cells
• Stem cells in regenerative therapies
• Stem cells in disease modeling and drug development
• Computational stem cell biology

Poster awards
There will be two poster awards for each poster session. The awardees will receive 500 €. Authors are asked to be present at the poster award ceremony, which will take place on Friday, 21 September 2018, 15.30 - 16.00 h in the main DKFZ lecture hall.

Oral Presentation
The first author of the abstract is intended to give the lecture. The talks will be 12 minutes long followed by 3 minutes discussion. Abstracts selected for oral presentation may in addition be shown as poster presentation to allow further discussion.

Poster presentation
In general abstracts are accepted for poster presentations.
However, abstracts can be rejected based on lack of scientific quality or for ethical or legal reasons. 

Posters will be displayed during the meeting in two poster sessions.
Authors are asked to be present at their poster during the poster session.

The size of a single poster should be not more than 1.2 m high x 1 m wide. Materials to fix your poster will be provided on site.

If you have any questions do not hesitate to contact the GSCN office or the technical support.

Supporters